1. NIH FIRST at Mount Sinai
medical student writing

Apply Now

The NIH FIRST at Mount Sinai program aims to build a self-reinforcing community of scientists committed to inclusive excellence. To accomplish this goal, we are recruiting a diverse group of top talent for research tenure-track faculty positions (Assistant Professor or equivalent level). Candidates must be able to demonstrate a strong commitment to promoting diversity and inclusive excellence.

Neurosciences

The Friedman Brain Institute is world-renowned for advancing our understanding of brain and nervous system disorders. Our researchers are pioneering innovative approaches to treatment and diagnostics through translational research.

Health Equity Research

The Institute for Health Equity Research brings together a multidisciplinary team to address disparities in health and health care that have long-standing roots in our country. Our team conducts groundbreaking research to engage at-risk communities, enable access to life-changing resources, and inform life-saving interventions.

Cancer/Oncology

The Tisch Cancer Institute is a National Cancer Institute-designated cancer center, known throughout the world for landmark cancer research and treatment. The mission of The Tisch Cancer Institute is to advance basic, clinical, and population health cancer research to help prevent and eradicate cancer. Our clinical breakthroughs have improved and saved the lives of our patients, their families, and the diverse communities we serve.

Microbiology

The Global Health and Emerging Pathogens Institute is the nucleus of the Icahn School of Medicine at Mount Sinai’s efforts on infectious diseases and the pathogens that cause them. The Institute is recognized internationally for its expertise in RNA virus research, and ongoing research on the molecular pathogenesis and host responses of influenza, HIV, Dengue, Zika, Ebola, and other emerging and re-emerging virus infections.

The NIH FIRST Cohort Cluster Hiring Initiative at Icahn Mount Sinai is supported by the National Cancer Institute of the National Institutes of Health under Award Number U54CA267776. This award is supported by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director.